Table 3 Major challenges regarding BC testing in sepsis routine identified in 79 ICUs and 59 LABs across four European countries
Challenges (%) | France | Germany | Italy | UK |
|---|---|---|---|---|
ICUs | Â | |||
No challenges | 50 | 62 | 18 | 38 |
Time constraints | 19 | 15 | 41 | 8 |
Cost pressure | 0 | 15 | 41 | 15 |
Insufficient training of personnel | 0 | 0 | 18 | 31 |
Excessive time to transport | 0 | 8 | 12 | 0 |
Poor communication with LAB | 13 | 0 | 6 | 0 |
Other | 25 | 0 | 6 | 8 |
LABs | Â | |||
No challenges | 19 | 31 | 18 | 46 |
Excessive time to transport | 4 | 37 | 23 | 0 |
Insufficient incoming sample volumes/number of BC sets | 43 | 42 | 0 | 21 |
Cost pressure | 9 | 16 | 54 | 29 |
Mislabeling of BC bottles | 13 | 0 | 23 | 4 |
Many false negatives | 9 | 21 | 8 | 17 |
Many false positives due to | Â | Â | Â | Â |
 Inappropriate taking of blood samples | 61 | 53 | 0 | 38 |
 Delayed transport to the LAB | 9 | 0 | 8 | 0 |
Low reactivity of clinicians | 0 | 11 | 0 | 4 |